Ki67 in breast cancer: prognostic and predictive potential
Top Cited Papers
- 28 February 2010
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 11 (2), 174-183
- https://doi.org/10.1016/s1470-2045(09)70262-1
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI Journal of the National Cancer Institute, 2009
- Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasionBMC Cancer, 2008
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor CharacteristicsJNCI Journal of the National Cancer Institute, 2008
- Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 2008
- Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapyAnnals of Oncology, 2007
- Letrozole in the neoadjuvant setting: the P024 trialBreast Cancer Research and Treatment, 2007
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patientsBritish Journal of Cancer, 2007
- Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozoleBritish Journal of Cancer, 2006
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004